QUETMOLIMAB

UNII:	G8NT4Q571B
Formula:
Preferred Substance Name:	QUETMOLIMAB
GSRS Full Record:	G8NT4Q571B i

2084037-83-0
E6011
E-6011
E6011, ANTI-CX3CL1 HUMANIZED IGG2, IN CHOK1SV (CHO CELL LINE)
IMMUNOGLOBULIN G2, ANTI-(HUMAN FRACTALKINE) (HUMANIZED MONOCLONAL E6011 .GAMMA.2-CHAIN), DISULFIDE WITH HUMANIZED MONOCONAL E6011 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS CX3CL1 (CHEMOKINE CX3-C MOTIF LIGAND 1, SCYD1, SMALL INDUCIBLE CYTOKINE SUBFAMILY D CYS-X3-CYSMEMBER 1, FRACTALKINE, FKN, NEUROTACTIN, NTN)), MONOCLONAL ANTIBODYGAMMA2 HEAVY CHAIN (1-445) (VH (MUS MUSCULUS IGHV1S56*01 (80.4%)-(IGHD)-IGHJ2*01 (93.3%)/HOMO SAPIENS IGHV1-46*01 (76.3%)-(IGHD)-IGHJ4*01 (93.3%)) (8.8.12) (1-119)-HOMO SAPIENS IGHG2*01 (CH1 (120-217), HINGE (218-229), CH2 V1.2>A (233), G1>A (235) (230-338), CH3 (339-443), CHS (444-445)) (120-445)), (133-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-NL1*01 (85.3%)-IGKJ4*01 (100%)) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214'))DIMER (221-221'':222-222'':225-225'':228-228'')-TETRAKISDISULFIDE
QUETMOLIMAB [INN]
QUETMOLIMAB [USAN]
QUETMOLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

QUETMOLIMAB

Synonyms and Mappings

Resources